BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7504012)

  • 1. Elevation of intracellular cAMP in human T lymphocytes by an anti-CD44 mAb.
    Rothman BL; Kennure N; Kelley KA; Katz M; Aune TM
    J Immunol; 1993 Dec; 151(11):6036-42. PubMed ID: 7504012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44.
    Rothman BL; Blue ML; Kelley KA; Wunderlich D; Mierz DV; Aune TM
    J Immunol; 1991 Oct; 147(8):2493-9. PubMed ID: 1833455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the CD3/T cell receptor (TcR) complex or of protein kinase C potentiate adenylyl cyclase stimulation in a tumoral T cell line: involvement of two distinct intracellular pathways.
    Bihoreau C; Heurtier A; Enjalbert A; Corvaïa N; Bensussan A; Degos L; Kordon C
    Eur J Immunol; 1991 Nov; 21(11):2877-82. PubMed ID: 1657616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes.
    Hahn WC; Rosenstein Y; Burakoff SJ; Bierer BE
    J Immunol; 1991 Jul; 147(1):14-21. PubMed ID: 1711070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin.
    Gouy H; Cefai D; Christensen SB; Debré P; Bismuth G
    Eur J Immunol; 1990 Oct; 20(10):2269-75. PubMed ID: 1700752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of peripheral T cell activation by coengagement of CD44 and CD2.
    Conrad P; Rothman BL; Kelley KA; Blue ML
    J Immunol; 1992 Sep; 149(6):1833-9. PubMed ID: 1381388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique CD44 monoclonal antibody identifies a new T cell activation pathway.
    Pierres A; Lipcey C; Mawas C; Olive D
    Eur J Immunol; 1992 Feb; 22(2):413-7. PubMed ID: 1347013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 contributes to T cell activation.
    Huet S; Groux H; Caillou B; Valentin H; Prieur AM; Bernard A
    J Immunol; 1989 Aug; 143(3):798-801. PubMed ID: 2568380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway.
    Anderson DL; Tsoukas CD
    J Immunol; 1989 Dec; 143(11):3647-52. PubMed ID: 2555413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential CD3/T cell antigen receptor-mediated IL-2 production in jurkat T cells. Dissociation of IL-2 response from total inositol phosphate and calcium responses.
    Stohl W; Hofman FM; Gray JD
    J Immunol; 1990 Aug; 145(4):1078-87. PubMed ID: 2143206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
    Bartik MM; Bauman GP; Brooks WH; Roszman TL
    Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to CD44 trigger effector functions of human T cell clones.
    Galandrini R; Albi N; Tripodi G; Zarcone D; Terenzi A; Moretta A; Grossi CE; Velardi A
    J Immunol; 1993 May; 150(10):4225-35. PubMed ID: 8097750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholera toxin inhibits the increase in cytoplasmic free calcium induced via the CD2 pathway of human T-lymphocyte activation.
    Nunes J; Bagnasco M; Lopez M; Olive D; Mawas C
    J Cell Biochem; 1989 Apr; 39(4):391-400. PubMed ID: 2542344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
    Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
    Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP-mediated alteration of the CD2 activation process in human T lymphocytes. Preferential inhibition of the phosphoinositide cycle-related transduction pathway.
    Bismuth G; Theodorou I; Gouy H; Le Gouvello S; Bernard A; Debré P
    Eur J Immunol; 1988 Sep; 18(9):1351-7. PubMed ID: 2901964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CD2-mediated human T cell activation: anti-CD8 monoclonal antibodies inhibit CD2-mediated rise in intracellular calcium.
    Franco MD; Nunes J; Lipcey C; Lopez M; Mawas C; Olive D
    Cell Immunol; 1993 Nov; 152(1):162-75. PubMed ID: 7902214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP inhibits the OKT3-induced increase in cytoplasmic free calcium in the Jurkat T cell line: the degree of inhibition correlates inversely with the amount of CD3 binding ligand used.
    Papadogiannakis N; Nordström TE; Andersson LC; Wolff CH
    Eur J Immunol; 1989 Oct; 19(10):1953-6. PubMed ID: 2555197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of synergy between Thy-1 and CD3/TCR complex in signal delivery to murine thymocytes for cell death.
    Nakashima I; Zhang YH; Rahman SM; Yoshida T; Isobe K; Ding LN; Iwamoto T; Hamaguchi M; Ikezawa H; Taguchi R
    J Immunol; 1991 Aug; 147(4):1153-62. PubMed ID: 1678398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb.
    Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
    J Immunol; 1993 Oct; 151(7):3547-56. PubMed ID: 7690806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression.
    Ledbetter JA; Parsons M; Martin PJ; Hansen JA; Rabinovitch PS; June CH
    J Immunol; 1986 Nov; 137(10):3299-305. PubMed ID: 3021852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.